)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Delhi's post-liberalisation growth turned it into a services powerhouse, but housing shortages, unplanned urbanisation, pollution and infrastructure gaps continue to test the capital
Delhi needs a virtual database to consolidate land records, while transit-oriented development norms under MPD 2047 aim to simplify development near transport corridors
Pharma sales value rose to Rs 23,272 crore in August, driven by new introductions and double-digit growth in key acute and chronic therapies, even as volume growth slowed
Healthcare-focused VC fund plans to deploy seed capital exclusively through a company creation model, targeting eight to 10 startups over a four-year investment period
Maharashtra FDA conducted 104 search and seizure operations between June and August, seizing illegal drugs and cosmetics worth Rs 11.41 crore and registering 20 FIRs
Novartis doubles down on innovation in India, eyeing R&D, clinical trials and a stronger regulatory ecosystem while moving away from traditional generics
On what will make India an attractive investment destination, Love said: ''I think the number one for us to make India attractive is to create an innovative ecosystem.''
Indian Immunologicals said Abhayrab anti-rabies vaccine vials declared NSQ and misbranded by a government laboratory were not manufactured by its human health division
CDSCO expert panel grants waiver for 920 mg Ocrelizumab, subject to Roche conducting a Phase 4 clinical trial in the Indian population for proposed indications
India's proposed rules for refurbished medical device imports remain unresolved nearly a year after a government panel was formed, amid safety concerns and demand from smaller hospitals
India will anchor the core of the CoE alongside a Dallas team as CBRE targets automation of 30 critical enterprise workflows over the next nine to 12 months
The five-year lease at Greater Noida's Golden Grande commercial hub covers 1,050 basement car parks and space for five containerised EV charging stations
Court seeks reconstruction of Singh brothers' share and asset trail
The developer will acquire 84.71 acres in Najafgarh through a Rs 420.2 crore non-cash share swap, marking its first residential entry into Delhi
Low pass rate brings overseas medical training under scrutiny
The expert panel recommends access to recorded responses for candidates, better examination-centre infrastructure and a fee review, but rules out grace marks for the June 2026 test
Semiconductor major will occupy 632,000 sq ft across 10 floors at Bagmane Solarium City under a 10-year lease starting on December 1, 2026, with rent rising 15 per cent every three years
Doctors call the pickup largely seasonal and say most H3N2 and H1N1 cases are being treated at home, with hospitalisations remaining limited so far
Over $300 billion in investment commitments to drive capacity expansion, with developers eyeing expansion in Delhi-NCR, Hyderabad mkts
With the economics of affordable rental housing remaining challenging due to razor-thin margins, development incentives are critical to attracting private capital at scale